BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17212121)

  • 1. [Hepatic lymph node involvement in patients with synchronous multiple liver metastases of colorectal cancer].
    Ishibashi K; Ohsawa T; Yokoyama M; Ishizuka N; Miyazaki T; Nakada H; Gonda T; Ishida H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1834-7. PubMed ID: 17212121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic lymph-node involvement in patients with synchronous liver metastasis from colorectal cancer-a correlation with the grading system for liver metastasis].
    Ishibashi K; Yokoyama M; Okada N; Ishiguro T; Ohsawa T; Mitsuhashi T; Miyazaki T; Matsuki M; Ishida H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2183-5. PubMed ID: 19106564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.
    Laurent C; Sa Cunha A; Rullier E; Smith D; Rullier A; Saric J
    J Am Coll Surg; 2004 Jun; 198(6):884-91. PubMed ID: 15194069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between the size and metastasis of hepatic lymph nodes in patients with synchronous liver metastasis of colorectal cancer].
    Ishibashi K; Sobajima J; Ohsawa T; Okada N; Yokoyama M; Mitsuhashi T; Miyazaki T; Nakada H; Gonda T; Ishida H
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):2035-7. PubMed ID: 18219890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection criteria for simultaneous resection in patients with synchronous liver metastasis.
    Minagawa M; Yamamoto J; Miwa S; Sakamoto Y; Kokudo N; Kosuge T; Miyagawa S; Makuuchi M
    Arch Surg; 2006 Oct; 141(10):1006-12; discussion 1013. PubMed ID: 17043279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
    Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
    Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lymph node dissection provides a survival benefit for patients with nodal disease of colorectal carcinoma liver metastases.
    Wakai T; Shirai Y; Sakata J; Nagahashi M; Kaneko K; Hatakeyama K
    Hepatogastroenterology; 2009; 56(89):186-90. PubMed ID: 19453055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of hepatic lymph node metastasis in liver metastases from colorectal cancer].
    Tajima Y; Ishibashi K; Ishiguro T; Ohsawa T; Okada N; Kumamoto K; Tsuji Y; Haga N; Iwama T; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2228-31. PubMed ID: 22202338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resection made possible following hepatic arterial infusion in 2 cases of hepatic metastases from colorectal cancer].
    Tsuji Y; Hamada H; Yasuda D; Okamura M; Watanabe K; Takahashi T; Takada J; Katsuki Y
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2100-3. PubMed ID: 12484012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphadenectomy in colorectal cancer liver metastases resection: incidence of hilar lymph nodes micrometastasis.
    Viana EF; Herman P; Siqueira SC; Taka T; Carvalho P; Coelho FF; Pugliese V; Saad WA; D'Albuquerque LA
    J Surg Oncol; 2009 Dec; 100(7):534-7. PubMed ID: 19653249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases.
    Beckurts KT; Hölscher AH; Thorban S; Bollschweiler E; Siewert JR
    Br J Surg; 1997 Aug; 84(8):1081-4. PubMed ID: 9278645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rule of lymph node metastasis in colorectal cancer and its affecting factors].
    Tu SL; Ye ZY; Deng GL; Zhao ZS; Dong QJ; Zheng BA; Ding LP; Cao HF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):257-60. PubMed ID: 17520386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological analysis of synchronous hepatic metastases from colorectal cancer].
    Ye YJ; Wang S; Wu J; Shen ZL; Yin MJ; Yang XD; Jiang KW; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 May; 11(3):208-12. PubMed ID: 18478460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of primary disease factors on outcome after resection of colorectal liver metastases?].
    Yamamoto J; Saiura A; Koga R; Seki M; Ueno M; Ohya M; Kuroyanagi H; Ohyama S; Fukunaga S; Hiki N; Seto Y; Yamaguchi T
    Nihon Geka Gakkai Zasshi; 2006 May; 107(3):109-15. PubMed ID: 16734266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T; Okada N; Nakada H; Yokoyama M; Miyazaki T; Ishibashi K; Ishida H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
    Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
    Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance].
    Li SY; Yu B; An P; Zuo FY; Cai HY
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1118-20. PubMed ID: 16194308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.